Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by venture009


T.ONC

RE:Like Clockwork.....

Angler, I have seen this type of comment now for years and so far they are...

October 19, 2023

T.ONC

RE:RE:RE:RE:RE:Biotech M&A is picking back up according to BiopharmaDive

Fox it s/b "years". Over the multitude of years this management...

October 15, 2023

T.ONC

RE:RE:RE:RE:Sanofi Exploring Acquisition of KRAS Cancer Drugmaker Mirati

Inorder for ONCY to get the attention required for any share appreciation, I...

October 9, 2023

V.CEC

RE:AGM

The problem is cash on hand.  They have been at this process for a...

October 5, 2023

T.ONC

RE:RE:RE:RE:RE:RE:Buy-out potential???

Angler that's why they need a catalyst like AA to kick start the sp...

October 3, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:oncolyticsbiotech(dot)com - site not accessible

Good one.

October 2, 2023

T.ONC

RE:90 Days Fireside Chat

Usually the market is the best barometer for such events and so far with the...

September 25, 2023

T.ONC

RE:RE:ONCY adds General Councel role to company roster

Let's hope he/she is doing something. They won't be cheap. May be...

September 22, 2023

T.ONC

RE:RE:RE:RE:Oh not again...

Azzak34, Quentin30 has history on his side. "Those that do not learn...

September 21, 2023

T.ONC

RE:RE:RE:Roche CEO Seeks High-Risk, High-Reward Drugs

Fox, doesn't seem the market shared Scooter's enthusiasm. Very low...

September 12, 2023

T.ONC

RE:RE:A/O Sept. 08th ONCY's cash runway is until late Q4, 2024

ONCY doesn't have the expertise to run two PIII trials. The investment...

September 9, 2023

T.ONC

RE:JNJ & Liver Cancer

I remember the same re reo's effectiveness on liver cancer. There was a...

September 9, 2023

T.ONC

RE:RE:RE:Leedjonesgable: Oncolytics Biotech Inc. | ONCY/ONC-TSX

Oncolytics Biotech® Enters into Common Stock Purchase Agreement for up...

September 8, 2023

T.ONC

Accelerated Approval

As Noteable has pointed out pela should receive AA. WIthout this approval I...

September 5, 2023

T.ONC

USA News Group

Discover the Hidden Potential of Oncolytics Biotech in Biden's $2.8...

August 31, 2023

T.ONC

RE:RE:Options have been issued

Must not be a blackout. So does this mean no meetings of consequence (ie. BP)...

August 18, 2023

T.ONC

RE:RE:RE:RE:RE:RE:Biogen’s $7.3 Bln acquisition of Reata followed bidding war

Agreed BH. Over the years we have had those with an over abundance of...

August 17, 2023

T.ONC

RE:RE:RE:RE:ONCY posts Q2'23 Financials & mBC intent

Noteable, most would agree with you re AA, especially because of the limited...

August 14, 2023

V.CEC

RE:Q-2

Radcat, over the years Pan Orient charged a considerable amount of G&A...

August 10, 2023

T.ONC

RE:RE:RE:RE:RE:Reality Check

Nice post Capitalista. I totally agree with your analysis. The old adage...

August 10, 2023

Prev 1 2 3 4 5 6 7 8 9 10 Next

Featured Company